TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2006

Phase II multicenter trial of docetaxel, epirubicin, and 5-fluorouracil (DEF) in the treatment of advanced gastric cancer: a novel, safe, and active regimen.

André M Murad et al.PubMed ↗Publisher ↗

No numbers read from the abstract.